BioLife Sciences Inc.
BioLife Sciences Inc. (BLFE) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001929281 · BLFE · OTC · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001929281 · Updated hourly · Not investment advice
Latest Key Filings
No recent filings
No recent filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
BioLife Sciences Inc. (OTC: BLFE) has submitted 24 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2005. As a Healthcare sector company with CIK 0001929281, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is BioLife Sciences Inc.'s most comprehensive regulatory disclosure. The most recent BioLife Sciences Inc. 10-K was filed on — for fiscal year ending —. Historical BLFE 10-K annual reports are available from 2022 through —.
Investors researching BioLife Sciences Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
BLFE SEC Filings · 8 questionsBioLife Sciences Inc. (BLFE) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 24 filings and access original documents at no cost. BioLife Sciences Inc.'s CIK is 0001929281.